scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1033819251 |
P356 | DOI | 10.1023/A:1023351819956 |
P698 | PubMed publication ID | 12779076 |
P5875 | ResearchGate publication ID | 10732453 |
P50 | author | Ilpo Huhtaniemi | Q27588685 |
Adam Zięcik | Q59161130 | ||
P2093 | author name string | Rabah Soliymani | |
Gabriel Bodek | |||
William Hansel | |||
Monika Zaleska | |||
Hikka Lankinen | |||
Nafis Ahmed Rahman | |||
P2860 | cites work | Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 |
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer | Q33765709 | ||
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics | Q33801855 | ||
Molecular targets for breast cancer therapy and prevention | Q33944781 | ||
Antibiotic peptides as mediators of innate immunity | Q33987884 | ||
Antibacterial peptides: key components needed in immunity | Q34098783 | ||
Primary structure of peptides and ion channels. Role of amino acid side chains in voltage gating of melittin channels | Q34126752 | ||
Glycoprotein Hormones: Structure and Function | Q34252688 | ||
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin | Q34322042 | ||
Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis | Q35983173 | ||
Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis | Q35993752 | ||
Recombinant Toxins for Cancer Treatment | Q36533609 | ||
The actions of melittin on membranes | Q37923509 | ||
Endocrine treatment of breast cancer in women | Q37938852 | ||
Targeted toxin therapy for the treatment of cancer | Q38288386 | ||
Immunotoxins: a clinical review of their use in the treatment of malignancies | Q38725006 | ||
Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer | Q41079089 | ||
The mouse inhibin alpha-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice | Q41197122 | ||
Annual hazard rates of recurrence for breast cancer after primary therapy. | Q50616854 | ||
Human chorionic gonadotropin and rat mammary cancer prevention. | Q53506326 | ||
Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. | Q55065991 | ||
Fluorescence, CD, attenuated total reflectance (ATR) FTIR, and 13C NMR characterization of the structure and dynamics of synthetic melittin and melittin analogues in lipid environments | Q67748016 | ||
Epidemiology of breast cancer | Q68675547 | ||
Evidence for the presence of luteinizing hormone/human chorionic gonadotropin-binding sites in the porcine uterus | Q70143999 | ||
A receptor binding site identified in the region 81-95 of the beta-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG) | Q72330395 | ||
Targeted approaches to cancer therapy | Q72668361 | ||
The presence of luteinizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glands | Q73208294 | ||
Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors | Q73422184 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1-10 | |
P577 | publication date | 2003-05-01 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate | |
P478 | volume | 79 |
Q34768470 | A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice. |
Q34116325 | Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer |
Q37218593 | LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment |
Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
Q36026107 | Nongonadal LH receptors, their involvement in female reproductive function and a new applicable approach. |
Q33672433 | Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate. |
Q50885951 | Protective Effects of Human Chorionic Gonadotropin Against Breast Cancer: How Can We Use This Information to Prevent/Treat the Disease? |
Q50878191 | Seasonal expressions of follicle-stimulating hormone receptor and luteinizing hormone receptor in the scented gland of the male muskrat (Ondatra zibethicus). |
Q37229453 | Serum follicle-stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post-menopausal females with breast cancer |
Search more.